Start LLC published research findings indicating that targeting cell division protein CDK2 could boost immunotherapy response across a wide range of cancers.

Start LLC is a product development company specializing in innovative design and engineering for the medical industry. Known for its creative concept development programs and its ability to generate prolific and valuable intellectual property, the company offers a complete product development service from project planning, industrial design and engineering to manufacturing support. Start LLC possesses diverse medical product experience including a variety of hand held devices, hospital products and implantables.

Founded 1995